Federal Register / Vol. 62, No. 56 / Monday, March 24, 1997 / Notices 13891

with provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and section 10(d) of Public Law 92–463,

for the review, discussion and

evaluation of individual grant

applications. These applications and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Ms. Maureen Mylander, Public Affairs

Officer, NCRR, National Institutes of

Health, 1 Rockledge Center, Room 5146,

6705 Rockledge Drive, MSC 7965,

Bethesda, Maryland 20892–7965, (301)

435–0888, will provide summaries of

meetings and rosters of committee

members. Other information pertaining

to the meetings can be obtained from the

Scientific Review Administrator

indicated. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

contact the Scientific Review

Administrator listed below, in advance

of the meeting.

Name of Committee: National Center for

Research Resources Initial Review Group—

Comparative Medicine Review Committee.

Dates of Meeting: June 2–3, 1997.

Place of Meeting: One Washington Circle

Hotel, The Caucus Room, One Washington

Circle, Washington, DC 20037, (202) 872–

1680.

Open: June 2, 8:00 a.m.–9:30 a.m.

Closed: June 2, 9:30 a.m.—until

adjournment.

Scientific Review Administrator: Dr.

Raymond O’Neill, National Institutes of

Health, 1 Rockledge Center, Room 6018, 6705

Rockledge Drive, MSC 7965, Bethesda, MD

20892–7965, Telephone: (301) 435–0820.

Name of Committee: National Center for

Research Resources Initial Review Group—

General Clinical Research Centers Review

Committee.

Date of Meeting: June 18–19, 1997.

Place of Meeting: Doubletree Hotel,

Regency Room, 1750 Rockville Pike,

Rockville, MD 20892, (301) 468–1100.

Open: June 18, 8:00 a.m.–10:00 a.m.

Closed: June 18, 10:00 a.m.–until

adjournment.

Scientific Review Administrator: Dr.

Charles Hollingsworth, National Institutes of

Health, 1 Rockledge Center, Room 6018, 6705

Rockledge Drive, MSC 7965, Bethesda, MD

20892–7965, Telephone: (301) 435–0818.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, Laboratory Animal

Sciences and Primate Research; 93.333,

Clinical Research, National Institutes of

Health)

Dated: March 18, 1997.

LaVerne Y. Stringfield,

Committee Management officer, NIH.

[FR Doc. 97–7264 Filed 3–21–97; 8:45 am]

BILLING CODE 4140–01–M

National Center for Research

Resources, Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Center for Research Resources

Special Emphasis Panel (SEP) meeting.

Name of SEP: Biomedical Research

Technology (Telephone Conference Call).

Date: April 10, 1997.

Time: 2:00 p.m.

Place: National Institutes of Health, 6705

Rockledge Drive, MSC 7965, Room 6018,

Bethesda, MD 20892–7965.

Contact Person: Dr. Bela Gulyas, Scientific

Review Administrator, 6705 Rockledge Drive,

MSC 7965, Room 6018, Bethesda, MD 20892–

7965, (301) 435–0811.

Purpose/Agenda: To evaluate and review

grant applications. This notice is being

published less than 15 days prior to the

above meeting due to the urgent need to meet

timing limitations imposed by the review and

funding cycle.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.371, Biomedical Research

Technology, National Institutes of Health,

HHS)

Dated: March 18, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–7266 Filed 3–21–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Amended Notice

of Meeting

Notice is hereby given of a change in

the meeting of the National Institute of

Allergy and Infectious Diseases Special

Emphasis Panel, TB Research Materials

and Vaccine Testing, March 31, 1997,

Teleconference Review, Solar Building,

Room 1A4, 6003 Executive Boulevard,

Bethesda, Maryland which was

published in the Federal Register on

March 11, 1997, Citation (62 FR 11215).

This committee was to have convened

at 2:00 p.m. on March 31, but the

meeting has been changed to 12:00 p.m.

on April 1, 1997, Solar Building, Room

1A4.

As previously announced, the

meeting will be closed to the public for

the review of contract proposals.

Dated: March 18, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–7265 Filed 3–21–97; 8:45 am]

BILLING CODE 4140–01–M

Natonal Institute of Health

National Institute of Allergy and

Infectious Diseases; Notice of Meeting:

AIDS Research Advisory Committee,

NIAID

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the AIDS Research Advisory Committee,

National Institute of Allergy and

Infectious Diseases, on May 20, 1997, in

Conference Room D of the Natcher

Conference Center, Building 45, at the

National Institutes of Health, 9000

Rockville Pike, Bethesda, Maryland.

The entire meeting will be open to the

public from 8:30 a.m. until

adjournment. The AIDS Research

Advisory Committee (ARAC) advises

and makes recommendations to the

Director, National Institute of Allergy

and Infectious Diseases, on all aspects of

research on HIV and AIDS related to the

mission of the Division of AIDS

(DAIDS).

The Committee will provide advice

on scientific priorities, policy, and

program balance at the Division level.

The Committee will review the progress

and productivity of ongoing efforts, and

identify critical gaps/obstacles to

progress. Attendance by the public will

be limited to space available.

Ms. Rona L. Siskind, Executive

Secretary, AIDS Research Advisory

Committee, DAIDS, NIAID, NIH, Solar

Building, Room 2A21, telephone 301–

435–3732, will provide a summary of

the meeting and a roster of committee

members upon request. Individuals who

plan to attend and need special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Siskind in advance of the meeting.

(Catalog of Federal Domestic Assistance

Program Nos. 93.855, Immunology, Allergic

and Immunologic Disease Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)